Targeting Tau: A New Hope for Alzheimer's | Global News

Scientists are racing to crack Alzheimer’s with a bold new drug, diranersen, which directly targets tau protein — the disease’s hidden driver — rather than amyloid. Early results hint at slowing progression, sparking hope for a fresh therapeutic path. Alongside this, researchers are testing tau vaccines, repurposed heart meds, and cholesterol drugs that may help those with genetic risk — all while tackling the brain’s toughest delivery hurdle. While still in early stages, this tau-focused revolution could redefine Alzheimer’s treatment — and bring real hope to millions. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0b036dac7154f568